HUAK
NASDAQ:HUAK
Huake Holding Biology Co., Ltd. Class A ordinary shares
- Stock
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '19 | Sep '20 | Sep '21 | Sep '22 | ||
|---|---|---|---|---|---|
average inventory | 3.73M - | 3.07M 17.79% | 3.76M 22.48% | ||
average payables | 121.86K - | 208.60K 71.18% | 518.03K 148.34% | ||
average receivables | 3.70M - | 6.70M 81.20% | 8.09M 20.73% | ||
book value per share | 2.12 - | 2.52 18.53% | 3.03 20.55% | 5.38 77.36% | |
capex per share | -0.01 - | -0.22 4,041.48% | -0.39 79.70% | -0.11 70.87% | |
capex to depreciation | -0.26 - | -10.77 4,056.49% | -19.03 76.67% | -3.53 81.45% | |
capex to operating cash flow | 0.65 - | -0.91 238.91% | -1.04 15.02% | -0.94 10.23% | |
capex to revenue | -0.00 - | -0.09 3,841.47% | -0.13 41.86% | -0.02 83.52% | |
cash per share | 0.00 - | 0.02 418.90% | 0.00 89.73% | 0.01 313.13% | |
days of inventory on hand | 92.08 - | 145.37 57.88% | 35.96 75.26% | 144.79 302.61% | |
days payables outstanding | 2.51 - | 5.23 108.41% | 6.03 15.35% | 18.90 213.43% | |
days sales outstanding | 51.36 - | 135.57 163.98% | 156.82 15.68% | 151.21 3.58% | |
debt to assets | 0.24 - | 0.26 10.59% | 0.26 0.90% | ||
debt to equity | 0.31 - | 0.35 14.31% | 0.36 1.21% | ||
dividend yield | |||||
earnings yield | 25.77K - | 27.26K 5.78% | 37.81K 38.67% | 90.88K 140.38% | |
enterprise value | -28.57K - | -148.53K 419.81% | -15.20K 89.77% | -38.11K 150.67% | |
enterprise value over ebitda | -0.01 - | -0.06 390.76% | -0.01 91.04% | -0.01 65.83% | |
ev to operating cash flow | 0.57 - | -0.10 117.44% | -0.01 93.45% | -0.08 1,177.04% | |
ev to sales | -0.00 - | -0.01 394.71% | -0.00 91.92% | -0.00 134.38% | |
free cash flow per share | -0.01 - | 0.02 265.57% | -0.02 175.88% | 0.01 145.27% | |
free cash flow yield | -1.32K - | 2.18K 265.57% | -1.66K 175.88% | 750.01 145.27% | |
graham net net | -0.19 - | 0.16 187.07% | -0.00 100.71% | 0.60 51,884.32% | |
graham number | 3.51 - | 3.93 11.97% | 5.08 29.30% | 10.49 106.48% | |
income quality | -0.03 - | 0.87 2,918.52% | 0.98 12.66% | 0.13 86.50% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | 1.11K - | ||||
interest debt per share | 0.00 - | ||||
inventory turnover | 3.96 - | 2.51 36.66% | 10.15 304.21% | 2.52 75.16% | |
invested capital | |||||
market cap | 62.50 - | 62.50 0% | 62.50 0% | 37.80 39.51% | |
net current asset value | 11.51M - | 12.50M 8.58% | 13.50M 8.05% | 15.14M 12.12% | |
net debt to ebitda | -0.01 - | -0.06 389.89% | -0.01 91.01% | -0.01 65.32% | |
net income per share | 0.26 - | 0.27 5.78% | 0.38 38.67% | 0.91 140.38% | |
operating cash flow per share | -0.01 - | 0.24 3,081.36% | 0.37 56.22% | 0.12 67.55% | |
payables turnover | 145.48 - | 69.80 52.02% | 60.52 13.31% | 19.31 68.09% | |
receivables turnover | 7.11 - | 2.69 62.12% | 2.33 13.55% | 2.41 3.71% | |
research and ddevelopement to revenue | |||||
return on tangible assets | 0.09 - | 0.08 13.66% | 0.09 14.67% | 0.13 36.95% | |
revenue per share | 2.23 - | 2.34 5.07% | 2.97 26.67% | 5.25 76.81% | |
roe | 0.12 - | 0.11 10.76% | 0.12 15.03% | 0.17 35.53% | |
roic | 0.09 - | 0.08 12.61% | 0.09 16.18% | 0.17 83.60% | |
sales general and administrative to revenue | 0.04 - | 0.05 10.96% | 0.03 41.91% | 0.02 10.09% | |
shareholders equity per share | 2.12 - | 2.52 18.53% | 3.03 20.55% | 5.38 77.36% | |
stock based compensation to revenue | |||||
tangible asset value | 13.26M - | 15.72M 18.53% | 18.95M 20.55% | 20.33M 7.28% | |
tangible book value per share | 2.12 - | 2.52 18.53% | 3.03 20.55% | 5.38 77.36% | |
working capital | 11.51M - | 12.50M 8.58% | 13.50M 8.05% | 15.14M 12.12% |
All numbers in USD (except ratios and percentages)